![This photo is of a male scientist sitting at a desk working with materials, wearing protective glasses.](/sites/default/files/styles/featured_square_large/public/2024-07/2023-P08173.jpg?h=c6980913&itok=LnJLvflD)
Filter News
Area of Research
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (6)
- (-) Clean Water (3)
- (-) Computer Science (14)
- (-) Cybersecurity (1)
- (-) Fusion (1)
- (-) Physics (2)
- (-) Transportation (6)
- 3-D Printing/Advanced Manufacturing (4)
- Artificial Intelligence (4)
- Big Data (1)
- Bioenergy (9)
- Biology (14)
- Biotechnology (3)
- Buildings (2)
- Chemical Sciences (2)
- Climate Change (3)
- Coronavirus (2)
- Decarbonization (3)
- Energy Storage (5)
- Environment (21)
- Exascale Computing (2)
- Frontier (1)
- Grid (1)
- High-Performance Computing (9)
- Isotopes (6)
- ITER (1)
- Materials (4)
- Materials Science (6)
- Mercury (3)
- Microscopy (3)
- Nanotechnology (3)
- National Security (4)
- Neutron Science (6)
- Nuclear Energy (4)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (4)
- Security (2)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (7)
Media Contacts
![Researchers studying secondary metabolites in the fungus Aspergillus flavus, pictured, found unique mixes of metabolites corresponding to genetically distinct populations. The finding suggests local environmental conditions play a key role in secondary metabolite production, influencing the discovery of drugs and other useful compounds. Credit: Tomás Allen Rush/ORNL, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2021-07/DSC0351.jpg?h=b2d9f031&itok=PNgYY5eW)
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![Peter Thornton, right, works with Robertsville Middle School students to assemble the RamSat. Credit: Ian Goethert/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/PXL_20210121_225402921.jpg?h=71976bb4&itok=C4lHQRhb)
RamSat’s mission is to take pictures of the forests around Gatlinburg, which were destroyed by wildfire in 2016. The mission is wholly designed and carried out by students, teachers and mentors, with support from numerous organizations, including Oak Ridge National Laboratory.
![L-R: ORNL’s Omer Onar and Veda Galigekere with the dynamic wireless charging test bed at ORNL’s Grid Research Integration and Deployment Center. Credit: Carlos Jones, ORNL/U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/2021-P03094.jpg?h=67a66a08&itok=P9ygUoBW)
Consumer buy-in is key to the future of a decarbonized transportation sector in which electric vehicles largely replace today’s conventionally fueled cars and trucks.
![Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/Deborah%20Frincke%20profile_0.jpg?h=8caed45b&itok=0eTC4gMH)
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
![ORNL’s Sergei Kalinin and Rama Vasudevan (foreground) use scanning probe microscopy to study bulk ferroelectricity and surface electrochemistry -- and generate a lot of data. Credit: Jason Richards/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/KalininVasudevan_2017-P03014_0.jpg?h=1116cd87&itok=KEEOB4hi)
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Heavy-duty vehicles contribute 23% of transportation emissions of greenhouse gases and account for almost one-quarter of the fuel consumed annually in the U.S. Credit: Chris Bair/Unsplash](/sites/default/files/styles/list_page_thumbnail/public/2021-04/highways_stock_0.jpg?h=1cbed347&itok=0cBMibFU)
Through a consortium of Department of Energy national laboratories, ORNL scientists are applying their expertise to provide solutions that enable the commercialization of emission-free hydrogen fuel cell technology for heavy-duty
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.